YTHDF1 and bladder transitional cell carcinoma: In addition, patients with higher YTHDF1 expression had poorer OS in mesothelioma (MESO) (n = 82, HR = 1.6, P = 0.049; Figure 2E) and uterine carcinosarcoma (UCS) (n = 740, HR = 2.2, P = 0.00097; Figure 2F), and also had poor DFS in BLCA (n = 400, HR = 1.5, P = 0.025; Figure 2G) and adrenocortical carcinoma (ACC) (n = 76, HR = 2, P = 0.046; Figure 2H).